Publication: Expression, purification, and crystallization of recombinant human ABL-1 kinase for X-ray crystallography
| dc.contributor.coauthor | Çiftçi, Halilibrahim | |
| dc.contributor.department | Graduate School of Sciences and Engineering | |
| dc.contributor.department | Department of Molecular Biology and Genetics | |
| dc.contributor.kuauthor | İrgit, Ayça | |
| dc.contributor.kuauthor | Demirci, Hasan | |
| dc.contributor.schoolcollegeinstitute | College of Sciences | |
| dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF SCIENCES AND ENGINEERING | |
| dc.date.accessioned | 2026-07-02T07:30:03Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Abelson-1 (ABL-1) is a nonreceptor tyrosine kinase that plays essential roles in various cellular processes, including proliferation, survival, differentiation and its kinase activity is tightly regulated. The dysregulated ABL-1 kinase activity is linked to disease pathogenesis like Chronic Myeloid Leukemia (CML), where the BCR | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.openaccess | Green Submitted, hybrid | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.sponsorship | This study was supported by the Health Institutes of Turkiye (TUSEB) under the grant number 24333. The authors thank TUSEB for their support. Grateful acknowledgement is extended to Reyhan Kam & imath;& scedil; for her contributions to the project, especially in crystallization trials. The authors gratefully acknowledge Assoc. Prof. Belgin Sever for her insightful contributions to the tyrosine kinase inhibitor research. | |
| dc.description.version | Published Version | |
| dc.identifier.WoSQuartile | Q3 | |
| dc.identifier.doi | 10.55730/1300-0527.3776 | |
| dc.identifier.embargo | No | |
| dc.identifier.issn | 1300-0527 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pubmed | 41798085 | |
| dc.identifier.scopus | 2-s2.0-105031649277 | |
| dc.identifier.uri | https://doi.org/10.55730/1300-0527.3776 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/33023 | |
| dc.identifier.volume | 50 | |
| dc.identifier.wos | 001704164200002 | |
| dc.keywords | ABL-1 kinase | |
| dc.keywords | Protein purification | |
| dc.keywords | X-ray crystallography | |
| dc.keywords | Chronic myeloid leukemia | |
| dc.language | eng | |
| dc.publisher | TUBITAK | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Turkish Journal of Chemistry | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.rights.uri | N/A | |
| dc.subject | Chemistry, multidisciplinary | |
| dc.subject | Engineering, chemical | |
| dc.title | Expression, purification, and crystallization of recombinant human ABL-1 kinase for X-ray crystallography | |
| dc.type | Journal Article | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | 3fc31c89-e803-4eb1-af6b-6258bc42c3d8 | |
| relation.isOrgUnitOfPublication | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 3fc31c89-e803-4eb1-af6b-6258bc42c3d8 | |
| relation.isParentOrgUnitOfPublication | af0395b0-7219-4165-a909-7016fa30932d | |
| relation.isParentOrgUnitOfPublication | 434c9663-2b11-4e66-9399-c863e2ebae43 | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | af0395b0-7219-4165-a909-7016fa30932d |
